SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending downwards, with community chatter focused on a sharp sell-off despite recent earnings and analyst upgrades, generating discussions around potential support levels and oversold conditions. Concerns over AI revenue specifics and margin impacts, as well as broader market rotation, are cited as possible catalysts. Some traders speculate about market manipulation, while others remain bullish, citing the company's AI backlog and potential for a rebound.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending downwards, with the community discussing the potential for further declines and key support levels, possibly driven by overall market concerns and sector-specific headwinds related to data center profitability. Investors are debating whether the recent drop represents a buying opportunity or a sign of deeper issues, with discussions around the company's fundamentals versus market sentiment. The conversation includes mentions of AI bubble fears, tax-loss harvesting, and potential rate hikes, adding to the uncertainty surrounding the stock.

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT ($LASR) is trending, with community members highlighting its potential involvement in the "Golden Dome" defense project and recent strong earnings. Some see a breakout opportunity if it can push through range highs on volume, while others discuss the company's technology and growth potential in the aerospace and defense sector. There is also discussion around possible short attacks.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as discussions revolve around the potential of its Greenland project and its role in securing critical mineral supply chains, particularly with recent drilling results highlighting multi-commodity potential. The community is actively discussing the implications of the project's resources, including zirconium, tantalum, yttrium, and cerium, for various high-tech applications. Community members are also weighing the potential for government stakes and how the company fits into the broader context of Western nations reducing reliance on Chinese mineral resources.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to a significant surge in price and volume, sparking discussions about a potential short squeeze. The community is actively debating its overnight trading activity and potential for further gains, drawing comparisons to other high-flying stocks. Some traders are pointing to the company's focus on AI-powered robotics as a reason for optimism, while others are wary of a potential pump and dump.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim data from its Phase 2b trial, sparking significant community discussion around its potential as a brain metastases imaging agent. Community members are actively discussing price targets and short squeeze opportunities, while also weighing the possibility of a near-term offering. The stock's aggressive volatility and high trading volume have placed it on many traders' watchlists.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

ARTV is trending due to a recent FDA Fast Track designation for its AlloNK cell therapy in rheumatoid arthritis, sparking significant price movement and high trading volume. The community is discussing the potential for continued gains, citing analyst price target upgrades and the company's strong cash position, while also weighing the possibility of a near-term offering. Some traders are closely watching key support and resistance levels to gauge the stock's next move.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community aims to revive "OG Memes" and the spirit of 2021, driven by bullish market sentiment and discussions around exchange listings. Community members are actively highlighting the strong community, potential for growth, and the ongoing efforts to build and innovate within the meme space. The focus remains on conviction, community ownership, and a return to the roots of internet meme culture.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amid discussions about AI integration, a potential rebound from recent underperformance, and a recent GSA deal.  The community is weighing the company's valuation and competitive positioning relative to peers, along with strong potential for AI-driven growth. Technical analysis suggests a potential breakout, with some eyeing price targets, while others express concerns about momentum and market manipulation.

$WORKIE is the official workers memecoin on Base.

Workie

Workie crypto is gaining attention as community members actively promote the token and share contract addresses. The community emphasizes the potential for financial independence, envisioning a future free from traditional work. Ongoing discussions focus on increasing visibility and encouraging further investment in Workie.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innoviva, Inc. (NASDAQ:INVA) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Innoviva, Inc. (NASDAQ:INVA - Get Free Report) have been given an average rating of "Moderate Buy" by the seven research firms that are presently covering the company, Marketbeat Ratings...

FDA Approves Innoviva's NUZOLVENCE, First-in-Class Oral Treatment For Gonorrhea

(RTTNews) - Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (INVA), announced that the U.S. Food and Drug Administration approved NUZOLVENCE (zoliflodacin) for oral suspension, a...

U.S. FDA Approves NUZOLVENCE (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE (zoliflodacin) for oral...

Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea

Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced the publication of positive results from a pivotal Phase 3 trial evaluating its investigational...

State Board of Administration of Florida Retirement System Cuts Stake in Innoviva, Inc. $INVA

State Board of Administration of Florida Retirement System decreased its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 80.4% in the second quarter, according to its most recent 13F filing...

Innoviva, Inc. $INVA Shares Purchased by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership raised its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 85.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...

Boston Partners Boosts Holdings in Innoviva, Inc. $INVA

Boston Partners lifted its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 40.6% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 875,084...

Innoviva, Inc. $INVA Shares Purchased by American Century Companies Inc.

American Century Companies Inc. raised its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 23.3% in the 2nd quarter, according to the company in its most recent 13F filing with the...

Jefferies Financial Group Inc. Increases Stake in Innoviva, Inc. $INVA

Jefferies Financial Group Inc. raised its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 421.0% during the 2nd quarter, according to the company in its most recent Form 13F...

Franklin Resources Inc. Reduces Holdings in Innoviva, Inc. $INVA

Franklin Resources Inc. reduced its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 63.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange...

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Current Price	$20.14
Prev Close	$20.63
Open	$20.63
Dividend Yield	0.00%
50-Day Moving Average	$19.55
Beta	0.34
Avg. Volume	933,052.37
PE Ratio	14.45

52-Week High	$22.76
52-Week Low	$16.52
Market Capitalization	$2.2B
EPS (Annual)	$0.3621
Price to Book	1.49
Revenue Per Employee	$2.93M
Enterprise Value/EBITDA	N/A

INVA
Innoviva Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INVA News

INVAInnoviva Inc